These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34524199)

  • 41. Molecular typing of Clostridioides difficile from frozen stool samples to investigate cross-transmissions: A proof of concept.
    Blanc DS; Poncet F; Grandbastien B; Prod'hom G; Greub G; Senn L
    Indian J Med Microbiol; 2022; 40(4):531-535. PubMed ID: 36008194
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay.
    Carroll KC; Buchan BW; Tan S; Stamper PD; Riebe KM; Pancholi P; Kelly C; Rao A; Fader R; Cavagnolo R; Watson W; Goering RV; Trevino EA; Weissfeld AS; Ledeboer NA
    J Clin Microbiol; 2013 Dec; 51(12):4120-5. PubMed ID: 24088862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
    Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.
    Camargo TS; Junior MS; Camargo LFA; Biotto VP; Doi AM; Koga PCM; França CN; Martino MDV
    Arch Microbiol; 2021 May; 203(4):1683-1690. PubMed ID: 33459815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of glutamate dehydrogenase (GDH) and toxin A/B rapid tests for Clostridioides (prev. Clostridium) difficile diagnosis in a university hospital in Minas Gerais, Brazil.
    Ramos CP; Lopes EO; Diniz AN; Lobato FCF; Vilela EG; Silva ROS
    Braz J Microbiol; 2020 Sep; 51(3):1139-1143. PubMed ID: 32367261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of a polymerase chain reaction method in the detection of Clostridioides difficile.
    Jaqueti Aroca J; Molina Esteban LM; García-Arata I; García-Martínez J; Cano De Torres I; Prieto Menchero S
    Rev Esp Quimioter; 2021 Apr; 34(2):141-144. PubMed ID: 33601876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
    Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of novel, cryptic
    Williamson CHD; Stone NE; Nunnally AE; Roe CC; Vazquez AJ; Lucero SA; Hornstra H; Wagner DM; Keim P; Rupnik M; Janezic S; Sahl JW
    Microb Genom; 2022 Feb; 8(2):. PubMed ID: 35166655
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of fecal Clostridium difficile load in discrepancies between toxin tests and PCR: is quantitation the next step in C. difficile testing?
    Leslie JL; Cohen SH; Solnick JV; Polage CR
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3295-9. PubMed ID: 22814877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples.
    Elfassy A; Kalina WV; French R; Nguyen H; Tan C; Sebastian S; Wilcox MH; Davies K; Kutzler MA; Jansen KU; Anderson A; Pride MW
    Anaerobe; 2021 Oct; 71():102415. PubMed ID: 34298152
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of testing methods on incidence of
    McCauley BP; Evans ME; Simbartl LA; Gamage SD; Kralovic SM; Roselle GA
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):461-463. PubMed ID: 33185177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
    Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of Clostridioides difficile toxin B gene: benefits of identifying gastrointestinal pathogens by mPCR assay in the diagnosis of diarrhea in pediatric patients.
    Byun JH; Yong D; Kim H
    BMC Infect Dis; 2022 Feb; 22(1):126. PubMed ID: 35123434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridium difficile infection.
    Smits WK; Lyras D; Lacy DB; Wilcox MH; Kuijper EJ
    Nat Rev Dis Primers; 2016 Apr; 2():16020. PubMed ID: 27158839
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
    Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
    Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
    Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
    [No Abstract]   [Full Text] [Related]  

  • 59. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.
    Sofjan AK; Islam MA; Halder K; Kabir ND; Saleh AA; Miranda J; Lancaster C; Begum K; Alam MJ; Garey KW
    Anaerobe; 2020 Feb; 61():102081. PubMed ID: 31356958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.